Photo taken from Tom Powles/X
May 18, 2024, 11:30
Tom Powles: Annual meeting of the CARE 1 metastatic 1st line RCC study
Tom Powles, Director of Barts Cancer Center, shared a post on X:
“Annual meeting of the CARE 1 metastatic 1st line RCC study which is open in France and will open in UK soon.
Biomarker driven trial (PD-L1) of ipi/nivo versus VEGF/PD1.
The Barts team in Paris enjoying the sunshine!”
Source: Tom Powles/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19